OSAIC HOLDINGS, INC. - GAIN THERAPEUTICS INC ownership

GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 25 filers reported holding GAIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.41 and the average weighting 0.0%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of GAIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$32,800
-26.8%
10,0000.0%0.00%
Q2 2023$44,800
-7.1%
10,0000.0%0.00%
Q1 2023$48,200
+55.5%
10,0000.0%0.00%
Q4 2022$31,000
-6.1%
10,0000.0%0.00%
Q3 2022$33,000
-8.3%
10,000
-1.0%
0.00%
Q2 2022$36,000
-12.2%
10,100
+0.5%
0.00%
Q1 2022$41,000
-24.1%
10,0500.0%0.00%
Q4 2021$54,00010,0500.00%
Other shareholders
GAIN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CM Management, LLC 90,000$295,2000.31%
Greenlight Capital 588,410$1,929,9850.11%
PRELUDE CAPITAL MANAGEMENT, LLC 58,100$190,5680.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 46,100$148,9030.00%
Householder Group Estate & Retirement Specialist, LLC 2,500$8,2000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HM PAYSON & CO 1,000$3,2800.00%
GROUP ONE TRADING, L.P. 1,937$6,2570.00%
GEODE CAPITAL MANAGEMENT, LLC 151,476$489,3550.00%
MORGAN STANLEY 1,300$4,2640.00%
View complete list of GAIN THERAPEUTICS INC shareholders